SurvivorNet: Advances in Metastatic Prostate Cancer
David R. Wise, MD, PhD
Photo: Juliana Thomas
Metastatic prostate cancer can be a scary diagnosis, but treatment options are increasing. Now, newer medications are being added to the current standard of care, androgen deprivation therapy, to help boost impact and delay progression of the cancer.
David R. Wise, MD, PhD, assistant professor of urology and medicine, Division of Hematology and Medical Oncology, spoke with SurvivorNet about the latest updates in this disease. Even though Dr. Wise says we're not at the point where we can give one treatment and the cancer is gone, "the treatment for metastatic prostate cancer has dramatically improved over the past 10 years."
Read more from SurvivorNet.
Healthline: Perlmutter Cancer Center Public Health Expert Discusses Increased Prostate Cancer Risk Factors for Black Men
Dr. Joseph E. Ravenell says Black men should discuss the benefits and risks of screening with their doctors.
ACCCBuzz: Perlmutter Cancer Center Medical Oncologist Discusses Progress & Need for Improvement in Treating Prostate Cancer
Dr. David R. Wise says long-term outcomes are far better than they were 10 years ago, but more can be done.